FindMyKOL
Clinical trialNCT00058331CompletedPhase 3Interventional

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

SponsorAlliance for Clinical Trials in OncologyEnrollment365AnemiaLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Epoetin alfa may stimulate red blood cell production and treat anemia in patients with solid tumors. It is not yet known whether epoetin alfa given once a week is more effective than epoetin alfa given once every 3 weeks in treating anemia. PURPOSE: Randomized phase III trial to study the effectiveness of epoetin alfa in treating anemia in patients who have solid tumors.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Mayo Clinic Scottsdale Oncology Program

    Scottsdale, Arizona, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Ccop - Illinois Oncology Research Association

    Peoria, Illinois, United States

  • Ccop - Carle Cancer Center

    Urbana, Illinois, United States

  • Ccop - Iowa Oncology Research Association

    Des Moines, Iowa, United States

  • Siouxland Hematology-Oncology

    Sioux City, Iowa, United States

  • Ccop - Wichita

    Wichita, Kansas, United States

  • Ccop - Michigan Cancer Research Consortium

    Ann Arbor, Michigan, United States

  • Ccop - Duluth

    Duluth, Minnesota, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Ccop - Missouri Valley Cancer Consortium

    Omaha, Nebraska, United States

  • Ccop - Merit Care Hospital

    Fargo, North Dakota, United States

  • Altru Cancer Center

    Grand Forks, North Dakota, United States

  • Ccop - Toledo Community Hospital

    Toledo, Ohio, United States

  • Ccop - Oklahoma

    Tulsa, Oklahoma, United States

  • Ccop - Geisinger Clinic and Medical Center

    Danville, Pennsylvania, United States

  • Rapid City Regional Hospital

    Rapid City, South Dakota, United States

  • Ccop - Sioux Community Cancer Consortium

    Sioux Falls, South Dakota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epoetin alfa →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2003
Primary completion
31 May 2006
Completion
31 May 2006
Last update posted
18 Jul 2016
Registered enrollment
365
Registry id
NCT00058331
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.